Insider Transactions in Q2 2024 at Guardant Health, Inc. (GH)
Insider Transaction List (Q2 2024)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Jun 30
2024
|
Amir Ali Talasaz Co-Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,809
-0.26%
|
$162,652
$28.88 P/Share
|
Jun 30
2024
|
Amir Ali Talasaz Co-Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
11,462
+0.52%
|
-
|
Jun 30
2024
|
Helmy Eltoukhy Co-Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,809
-0.25%
|
$162,652
$28.88 P/Share
|
Jun 30
2024
|
Helmy Eltoukhy Co-Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
11,462
+0.49%
|
-
|
Jun 30
2024
|
Steve E. Krognes Director |
BUY
Exercise of conversion of derivative security
|
Direct |
154
+1.63%
|
-
|
Jun 15
2024
|
Musa Tariq Director |
BUY
Exercise of conversion of derivative security
|
Direct |
250
+6.25%
|
-
|
Jun 15
2024
|
Chris Freeman Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,870
-10.45%
|
$86,100
$30.21 P/Share
|
Jun 15
2024
|
Chris Freeman Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,402
+17.46%
|
-
|
Jun 15
2024
|
Kumud Kalia Chief Information Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
896
-5.03%
|
$26,880
$30.21 P/Share
|
Jun 15
2024
|
Kumud Kalia Chief Information Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,510
+12.35%
|
-
|
Jun 15
2024
|
Myrtle S Potter Director |
BUY
Exercise of conversion of derivative security
|
Direct |
68
+0.51%
|
-
|
Jun 15
2024
|
John G. Saia Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,434
-4.8%
|
$43,020
$30.21 P/Share
|
Jun 15
2024
|
John G. Saia Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,017
+11.86%
|
-
|
Jun 15
2024
|
Michael Brian Bell Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,307
-15.23%
|
$99,210
$30.21 P/Share
|
Jun 15
2024
|
Michael Brian Bell Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
9,267
+17.63%
|
-
|
Jun 15
2024
|
Craig Eagle Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,971
-10.18%
|
$59,130
$30.21 P/Share
|
Jun 15
2024
|
Craig Eagle Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,523
+22.19%
|
-
|
Jun 12
2024
|
Meghan V. Joyce Director |
BUY
Exercise of conversion of derivative security
|
Direct |
5,592
+35.38%
|
-
|
Jun 12
2024
|
Steve E. Krognes Director |
BUY
Exercise of conversion of derivative security
|
Direct |
5,592
+37.96%
|
-
|
Jun 12
2024
|
Myrtle S Potter Director |
BUY
Exercise of conversion of derivative security
|
Direct |
5,592
+29.69%
|
-
|
Jun 12
2024
|
Ian T Clark Director |
BUY
Exercise of conversion of derivative security
|
Direct |
6,776
+30.18%
|
-
|
Jun 12
2024
|
Vijaya Gadde Director |
BUY
Exercise of conversion of derivative security
|
Direct |
5,592
+24.07%
|
-
|
Jun 04
2024
|
Meghan V. Joyce Director |
SELL
Open market or private sale
|
Direct |
100
-2.12%
|
$2,700
$27.87 P/Share
|
Jun 04
2024
|
Meghan V. Joyce Director |
BUY
Exercise of conversion of derivative security
|
Direct |
67
+1.4%
|
-
|
Jun 01
2024
|
John G. Saia Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
94
-0.36%
|
$2,538
$27.1 P/Share
|
Jun 01
2024
|
John G. Saia Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
263
+1.0%
|
-
|
Jun 01
2024
|
Darya Chudova Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
113
-0.26%
|
$3,051
$27.1 P/Share
|
Jun 01
2024
|
Darya Chudova Chief Technology Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
315
+0.72%
|
-
|
Jun 01
2024
|
Kumud Kalia Chief Information Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
254
-1.63%
|
$6,858
$27.1 P/Share
|
Jun 01
2024
|
Kumud Kalia Chief Information Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
711
+4.37%
|
-
|
May 31
2024
|
Steve E. Krognes Director |
BUY
Exercise of conversion of derivative security
|
Direct |
155
+4.19%
|
-
|
May 15
2024
|
Myrtle S Potter Director |
BUY
Exercise of conversion of derivative security
|
Direct |
69
+0.89%
|
-
|
May 15
2024
|
Musa Tariq Director |
BUY
Exercise of conversion of derivative security
|
Direct |
250
+6.67%
|
-
|
May 15
2024
|
Darya Chudova Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,106
-6.74%
|
$77,650
$25.75 P/Share
|
May 15
2024
|
Darya Chudova Chief Technology Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,705
+15.88%
|
-
|
May 15
2024
|
Craig Eagle Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,327
-8.75%
|
$33,175
$25.75 P/Share
|
May 15
2024
|
Craig Eagle Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,717
+19.68%
|
-
|
May 04
2024
|
Meghan V. Joyce Director |
BUY
Exercise of conversion of derivative security
|
Direct |
66
+1.4%
|
-
|
May 03
2024
|
Helmy Eltoukhy Co-Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
200,000
+8.02%
|
$800,000
$4.18 P/Share
|
May 02
2024
|
Amir Ali Talasaz Co-Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
283,830
+11.46%
|
$1,135,320
$4.18 P/Share
|
Apr 30
2024
|
Steve E. Krognes Director |
BUY
Exercise of conversion of derivative security
|
Direct |
154
+4.34%
|
-
|
Apr 15
2024
|
John G. Saia Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,809
-7.29%
|
$64,753
$17.06 P/Share
|
Apr 15
2024
|
John G. Saia Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,569
+21.06%
|
-
|
Apr 15
2024
|
Musa Tariq Director |
BUY
Exercise of conversion of derivative security
|
Direct |
249
+7.12%
|
-
|
Apr 15
2024
|
Myrtle S Potter Director |
BUY
Exercise of conversion of derivative security
|
Direct |
68
+0.89%
|
-
|
Apr 04
2024
|
Meghan V. Joyce Director |
BUY
Exercise of conversion of derivative security
|
Direct |
67
+1.44%
|
-
|
Apr 01
2024
|
John G. Saia Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
400
-1.79%
|
$8,000
$20.25 P/Share
|
Apr 01
2024
|
John G. Saia Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
974
+4.18%
|
-
|
Apr 01
2024
|
Craig Eagle Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
621
-5.14%
|
$12,420
$20.25 P/Share
|
Apr 01
2024
|
Craig Eagle Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,714
+12.43%
|
-
|